Top 10 Companies in the Nervous Acid Market (2026): Market Leaders Powering Global Neurological Therapies

MARKET INSIGHTS

The Global nervous acid market size was valued at USD 38.2 million in 2024. The market is projected to grow from USD 40.7 million in 2025 to USD 61.69 million by 2034, exhibiting a CAGR of 6.5% during the forecast period.

Br/>Nervous Acid Market – View in Detailed Research Report

Nervous acid (C24:1n-9) is a monounsaturated omega‑9 fatty acid that plays a critical role in neurological functions and nerve cell membrane structure. This specialized lipid component is primarily found in brain tissue and peripheral nerves, where it contributes to myelin sheath formation and neural signal transmission. While naturally occurring in human milk and certain fish oils, nervous acid has gained pharmaceutical importance for its potential applications in treating neurodegenerative disorders.

The market growth is driven by increasing neurological disorder prevalence, with Alzheimer’s disease affecting over 55 million people globally as of 2024. Rising R&D investments in neuroprotective compounds and growing demand for neurological health supplements are accelerating market expansion. The pharmaceutical sector accounts for 62% of current applications, though nutraceutical use is growing at 7.2% annually. Major industry players like BASF and DSM have recently expanded their nervous acid production capacities to meet the projected demand.

Top 10 Companies in the Nervous Acid Market (2026)

1️⃣ 1. Aktin Chemicals, Inc.

Headquarters: Shanghai, China
Key Offering: High‑purity Nervous Acid (98%+), custom synthesis services

Aktin Chemicals has positioned itself as a leading supplier of high‑purity nervous acid for pharmaceutical and research applications. Their advanced biotechnological platform allows precise control over product purity, meeting stringent regulatory standards required for CNS drug development.

Sustainability & Growth Initiatives:

• Investment in bio‑fermentation processes to reduce carbon footprint
• Partnerships with academic institutions for joint research on neuroprotective therapies
• Expansion of production capacity to 250,000 kg/year by 2030

2️⃣ 2. Changsha Staherb Natural Ingredients Co., Ltd.

Headquarters: Changsha, China
Key Offering: Functional‑grade nervous acid (90%+), nutraceutical formulations

Changsha Staherb specializes in cost‑effective nervous acid for the nutraceutical market, leveraging its extensive supply chain to deliver high‑quality ingredients at competitive prices.

Sustainability & Growth Initiatives:

• Adoption of renewable energy in manufacturing facilities
• Development of plant‑based supplement lines incorporating nervous acid
• Strategic alliances with Southeast Asian distributors to penetrate emerging markets

3️⃣ 3. Medkoo Biosciences, Inc.

Headquarters: San Francisco, USA
Key Offering: Custom API synthesis, formulation support for CNS therapeutics

Medkoo Biosciences offers end‑to‑end solutions for nervous acid, from raw material synthesis to final API, enabling pharma companies to accelerate product development.

Sustainability & Growth Initiatives:

• Implementation of green chemistry protocols to minimize waste
• Investment in AI‑driven process optimization
• Expansion of R&D center focused on neuroprotective drug delivery

4️⃣ 4. Cayman Chemical Company

Headquarters: Cayman Islands, USA
Key Offering: Research‑grade nervous acid, custom synthesis

Cayman Chemical serves the academic and biotech sectors with high‑purity nervous acid for preclinical studies and early‑phase drug discovery.

Sustainability & Growth Initiatives:

• Enhanced quality control systems for batch consistency
• Collaboration with universities on neurochemical research projects
• Adoption of ISO 9001 and ISO 14001 certifications

5️⃣ 5. Tokyo Chemical Industry Co., Ltd.

Headquarters: Tokyo, Japan
Key Offering: High‑purity nervous acid, specialty chemical solutions

Tokyo Chemical Industry leverages its long‑standing expertise in specialty chemicals to supply nervous acid for both pharmaceutical and industrial applications.

Sustainability & Growth Initiatives:

• Development of low‑energy synthesis routes
• Strategic partnership with Japanese biotech firms for CNS drug development
• Investment in digital supply chain transparency

6️⃣ 6. Abcam plc

Headquarters: Cambridge, UK
Key Offering: Research reagents, nervous acid for antibody production

Abcam provides nervous acid as a critical reagent for neuroscience research, supporting antibody development and functional studies.

Sustainability & Growth Initiatives:

• Commitment to sustainable sourcing of raw materials
• Investment in research collaborations with leading neuroscience institutes
• Implementation of carbon‑neutral logistics solutions

7️⃣ 7. Santa Cruz Biotechnology, Inc.

Headquarters: Dallas, USA
Key Offering: Nervous acid for research and diagnostic kits

Santa Cruz Biotechnology supplies nervous acid to support a wide range of neurobiological assays and diagnostic tools.

Sustainability & Growth Initiatives:

• Adoption of eco‑friendly packaging
• Collaboration with biotech startups for novel CNS therapeutics
• Investment in advanced purification technologies

8️⃣ 8. BOC Sciences

Headquarters: San Diego, USA
Key Offering: High‑purity nervous acid, custom synthesis for pharma

BOC Sciences specializes in delivering nervous acid with stringent purity requirements for pharmaceutical development.

Sustainability & Growth Initiatives:

• Implementation of water‑recycling systems in production plants
• Partnerships with pharmaceutical companies for joint R&D
• Expansion of capacity to meet growing demand in North America

9️⃣ 9. AdooQ BioScience, LLC

Headquarters: San Francisco, USA / Shanghai, China
Key Offering: Dual‑market nervous acid, tailored for pharma and nutraceutical segments

AdooQ BioScience bridges the gap between high‑purity pharmaceutical needs and cost‑effective nutraceutical formulations.

Sustainability & Growth Initiatives:

• Adoption of circular economy principles in manufacturing
• Strategic alliances with global health product brands
• Investment in digital platforms for supply chain optimization

🔟 10. ApexBio Technology

Headquarters: San Jose, USA / Taipei, Taiwan
Key Offering: Advanced nervous acid formulations, custom synthesis services

ApexBio Technology focuses on developing next‑generation nervous acid products for CNS drug discovery and nutraceutical applications.

Sustainability & Growth Initiatives:

• Implementation of green chemistry in synthesis processes
• Collaboration with academic research centers on neuroprotective therapies
• Expansion of global distribution network across Asia-Pacific

Br/>Download FREE Sample Report: Nervous Acid Market – View in Detailed Research Report

Br/>Get Full Report: Nervous Acid Market – View in Detailed Research Report

Outlook

The Nervous Acid market is poised for robust growth driven by escalating prevalence of neurological disorders and a surge in R&D investments. Forecasts indicate a steady CAGR of 6.5% from 2025 to 2034, with the market expanding from USD 40.7 million to USD 61.69 million. Pharmaceutical applications will dominate market share, while nutraceutical segments are expected to grow at 7.2% annually, reflecting heightened consumer demand for brain‑health supplements.

Future Trends

Key future trends include: 1) Increased adoption of personalized medicine platforms that integrate nervous acid into tailored CNS therapies; 2) Growth of nanotechnology‑based delivery systems enhancing bioavailability; 3) Expansion of sustainable bio‑fermentation manufacturing to meet environmental standards; 4) Rise of digital health and tele‑medicine platforms facilitating prescription of nervous acid‑based therapeutics; 5) Greater regulatory support for GABA‑derivative approvals, accelerating market penetration.